Omega-3 لـ Metabolic Syndrome

B الأدلة تدعم ذلك تجربة عشوائية واحدة على الأقل، مع نتائج متسقة في معظمها.

Systematic review of 44 RCTs found omega-3 significantly reduces triglycerides by 15-30% and reduces waist circumference by 0.81 cm. Fish oil combined with exercise produces greater body fat reduction than either alone. Benefits include PPAR-gamma activation and anti-inflammatory effects.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dmetabolic\u002Dsyndrome'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

الخلاصة

Key Study Findings

Randomized Controlled Trial 12 weeks Open-label

Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized …

Dose: Mediterranean diet مقابل: Standard diet Outcome: HDL/LDL subfractions and metabolic syndrome التأثير: None None

المجتمع المدروس: Patients with psoriatic arthritis

Review

A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation.

Dose: None مقابل: None Outcome: Chronic inflammation linking stress, depression, IR التأثير: None None

المجتمع المدروس: Review of metabolic syndrome and depression

Randomized Controlled Trial n=45 16 weeks

Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids.

Dose: 4 g/day P-OM3 مقابل: Healthy controls + MetSyn placebo Outcome: Lipoprotein oxylipin profiles التأثير: None None

المجتمع المدروس: MetSyn patients vs healthy controls

Review

Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome.

Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: None

Key Statistics

الدراسات

3000

المشاركون

↑

Positive

التقييم

Referenced Papers

Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized trial-the DIETA trial. RCT

Advances in rheumatology … 2024

A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation. Review

Biochemistry and biophysics … 2023 66 اقتباسات

Comments on "dose-related meta-analysis for omega-3 fatty acids supplementation on major adverse cardiovascular events". Other

Clinical nutrition (Edinburgh, … 2022 1 اقتباسات

Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids. RCT

Prostaglandins, leukotrienes, and … 2018 38 اقتباسات

Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. Review

Prostaglandins & other … 2015 182 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:: 250-500 mg EPA+DHA/day
antiinflammatory:: 2,000-4,000 mg/day
weightmanagement:: 1,000-3,000 mg EPA+DHA/day

الحد الأعلى: 5,000 mg EPA+DHA/day (FDA GRAS); may increase bleeding time at high doses

الجرعات المدروسة في الأبحاث

الجرعة	المدة	التأثير	ن
Mediterranean diet	12 weeks	Positive	--
None	--	Neutral	--
4 g/day P-OM3	16 weeks	Positive	45
None	--	Positive	--

أفضل وقت للتناول: With meals containing fat for absorption; may split dose AM/PM

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

⚠ Fishy aftertaste
⚠ GI discomfort
⚠ Increased bleeding time (at high doses)
⚠ Nausea

التفاعلات المعروفة

● Blood thinners (may enhance anticoagulant effect at high doses)
● Blood pressure medications (additive effect)
● Orlistat (reduced absorption)

الحد الأقصى المسموح به: 5,000 mg EPA+DHA/day (FDA GRAS); may increase bleeding time at high doses

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Omega-3 help with Metabolic Syndrome?

Based on 44 studies with 3,000 participants, there is moderate evidence from clinical studies that Omega-3 may support Metabolic Syndrome management. Our evidence grade is B (Good Evidence).

How much Omega-3 should I take for Metabolic Syndrome?

Studies have used various dosages. A commonly studied range is 250-500 mg EPA+DHA/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Omega-3?

Reported side effects may include Fishy aftertaste, GI discomfort, Increased bleeding time (at high doses), Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Omega-3 and Metabolic Syndrome?

We rate the evidence as Grade B (Good Evidence). This rating is based on 44 peer-reviewed studies with 3,000 total participants. The overall direction of effect is positive.

مكونات أخرى لـ Metabolic Syndrome

Berberine A Magnesium B Taurine B

Omega-3 لحالات أخرى

Abdominal Fat Reduction B Cortisol-Related Weight Gain C

الخلاصة السريعة

Evidence Strength72%

High confidence

تفصيل الدراسات

RCT (2)Meta (0)Other (42)

قارن البدائل

اعرف كيف تقارن المكونات الأخرى لهذه الحالة.

عرض جميع المكونات لـ Metabolic Syndrome

اعرف المزيد

References

[1] Daniele Scherer et al.. Adv Rheumatol. 2024. Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized trial-the DIETA trial. doi:10.1186/s42358-024-00389-5 PubMed
[2] Seema Mehdi et al.. Biochem Biophys Rep. 2023. A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation. doi:10.1016/j.bbrep.2023.101571 PubMed
[3] Jannis Kountouras et al.. Clin Nutr. 2022. Comments on "dose-related meta-analysis for omega-3 fatty acids supplementation on major adverse cardiovascular events". doi:10.1016/j.clnu.2022.06.015 PubMed
[4] Gregory C Shearer et al.. Prostaglandins Leukot Essent Fatty Acids. 2018. Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids. doi:10.1016/j.plefa.2017.10.006 PubMed
[5] Leyre Martínez-Fernández et al.. Prostaglandins Other Lipid Mediat. 2015. Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. doi:10.1016/j.prostaglandins.2015.07.003 PubMed

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.